We observed significant anti-tumor effects of all the anti-PD-L1, anti-PD-1 and anti-CTLA-4 mAbs on tumor cells even in the absence of T-cells, thus supporting the hypothesis that ICs could play an additional role in promoting tumor cell survival and proliferation [6,28]. This evidence concerns the gene CTLA4 and neoplasm.